These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 20221685)
1. VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH Mol Cell Biol; 2005 Apr; 25(8):3163-72. PubMed ID: 15798202 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
4. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate. Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067 [TBL] [Abstract][Full Text] [Related]
5. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein. Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425 [TBL] [Abstract][Full Text] [Related]
6. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
7. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
8. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis]. Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952 [TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011 [TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619 [TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795 [TBL] [Abstract][Full Text] [Related]
12. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related]
13. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Haase VH; Glickman JN; Socolovsky M; Jaenisch R Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1583-8. PubMed ID: 11171994 [TBL] [Abstract][Full Text] [Related]
14. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase. Park SK; Haase VH; Johnson RS Int J Oncol; 2007 Feb; 30(2):341-8. PubMed ID: 17203215 [TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model. Bader HL; Hsu T BMC Cancer; 2016 Oct; 16(1):797. PubMed ID: 27733136 [TBL] [Abstract][Full Text] [Related]
17. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148 [TBL] [Abstract][Full Text] [Related]
19. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Rankin EB; Tomaszewski JE; Haase VH Cancer Res; 2006 Mar; 66(5):2576-83. PubMed ID: 16510575 [TBL] [Abstract][Full Text] [Related]